文献速递慢性肾脏病血液净化与透析

从CKD到ESRD心脏超声指标演变与全因死亡风险:CRIC研究

Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.
PubMed 文献 · Am J Kidney Dis · 2018-05-18

本研究基于CRIC队列417例有CKD期和ESRD期心脏超声的CKD患者,分析从CKD到ESRD心脏结构功能指标变化及与透析后全因死亡的关系。平均2.9年间LVEF下降、LVESV增加,LVEF和LVESV恶化独立关联透析后死亡风险升高。

要点

  • 从CKD到ESRD,LVEF和LVESV恶化与透析后死亡风险独立相关。
  • LVEF每下降1%,透析后死亡风险增加3%(aHR 1.03)。
  • LVESV每增加1 mL/m2.7,透析后死亡风险增加4%(aHR 1.04)。

核心结论

  • 在CKD进展至透析的患者中,LVEF和LVESV恶化与透析后全因死亡风险升高独立相关。

研究设计与样本

  • 前瞻性研究,纳入CRIC队列中417例在CKD期和ESRD期均有研究心脏超声的CKD患者。

主要发现

  • 两次超声平均间隔2.9年,LVEF从52.5%降至48.6%(P<0.001),LVESV从18.6增至20.2 mL/m2.7(P<0.001)。
  • LVMI从60.4降至58.4 g/m2.7(P=0.005),中度/重度舒张松弛异常比例从11.11%降至4.94%(P=0.02)。
  • 左房容积从4.09至4.15 mL/m2(P=0.08)和LVEDV从38.6至38.4 mL/m2.7(P=0.8)变化无统计学意义。
  • LVEF每下降1%,透析后死亡aHR为1.03(95% CI 1.00-1.06)。
  • LVESV每增加1 mL/m2.7,透析后死亡aHR为1.04(95% CI 1.02-1.07)。

临床怎么用

  • 在CKD向ESRD过渡期间监测LVEF和LVESV变化,可能有助于识别透析后死亡高风险患者。

局限性

  • 部分心脏超声缺失或技术不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Abnormal cardiac structure and function are common in chronic kidney disease (CKD) and end-stage renal disease (ESRD) and linked with mortality and heart failure. We examined changes in echocardiographic measures during the transition from CKD to ESRD and their associations with post-ESRD mortality. STUDY DESIGN: Prospective study. SETTING & PARTICIPANTS: We studied 417 participants with CKD in the Chronic Renal Insufficiency Cohort (CRIC) who had research echocardiograms during CKD and ESRD. PREDICTOR: We measured change in left ventricular mass index, left ventricular ejection fraction (LVEF), diastolic relaxation (normal, mildly abnormal, and moderately/severely abnormal), left ventricular end-systolic (LVESV), end-diastolic (LVEDV) volume, and left atrial volume from CKD to ESRD. OUTCOMES: All-cause mortality after dialysis therapy initiation. ANALYTICAL APPROACH: Cox proportional hazard models were used to test the association of change in each echocardiographic measure with postdialysis mortality. RESULTS: Over a mean of 2.9 years between pre- and postdialysis echocardiograms, there was worsening of mean LVEF (52.5% to 48.6%; P<0.001) and LVESV (18.6 to 20.2mL/m2.7; P<0.001). During this time, there was improvement in left ventricular mass index (60.4 to 58.4g/m2.7; P=0.005) and diastolic relaxation (11.11% to 4.94% with moderately/severely abnormal; P=0.02). Changes in left atrial volume (4.09 to 4.15mL/m2; P=0.08) or LVEDV (38.6 to 38.4mL/m2.7; P=0.8) were not significant. Worsening from CKD to ESRD of LVEF (adjusted HR for every 1% decline in LVEF, 1.03; 95% CI, 1.00-1.06) and LVESV (adjusted HR for every 1mL/m2.7 increase, 1.04; 95% CI, 1.02-1.07) were independently associated with greater risk for postdialysis mortality. LIMITATIONS: Some missing or technically inadequate echocardiograms. CONCLUSIONS: In a longitudinal study of patients with CKD who subsequently initiated dialysis therapy, LVEF and LVESV worsened and were significantly associated with greater risk for postdialysis mortality. There may be opportunities for intervention during this transition period to improve outcomes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Bansal N, Roy J, Chen HY, et al. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study. Am J Kidney Dis. 2018. PMID: 29784617. doi:10.1053/j.ajkd.2018.02.363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。